Invesco Mutual Fund has launched the Invesco India Pharma and Healthcare Fund, an open-ended equity scheme investing across pharma, healthcare and allied sectors, the company said in a press release.
The New Fund Offer (NFO) opened for subscription on August 18, 2026 and will close on September 1, 2026.
The fund will invest across the healthcare value chain, including pharmaceutical companies, hospitals, diagnostics, contract development and manufacturing organisations (CDMOs), contract research organisations (CROs), medical devices, healthcare services, insurance and other allied segments.
The fund will be managed by Aditya Khemani and will be benchmarked against the BSE Healthcare TRI.
In a press release, Aditya Khemani, Head of Equity & Fund Manager, Invesco MF, said, “India’s healthcare sector is undergoing a structural transformation. The country is not only witnessing rising healthcare consumption driven by favourable demographics and increasing affordability but is also strengthening its position as a global pharmaceutical and healthcare innovation hub. We see attractive opportunities across domestic pharma, hospitals, diagnostics, CDMOs and emerging healthcare segments that can potentially benefit from this multi-year growth cycle. Our investment approach will focus on identifying quality businesses with sustainable competitive advantages and strong growth visibility across the healthcare ecosystem.”
The scheme will charge an exit load of 0.50% if units are redeemed or switched out within three months from the date of allotment. No exit load will be charged for redemptions after three months.
For distributors, the fund offers exposure to a wider healthcare universe rather than focusing only on traditional pharmaceutical companies, with investments spread across multiple segments of the healthcare ecosystem.
Key takeaways:
- The scheme will invest across pharma, hospitals, diagnostics, CDMOs, CROs, medical devices, healthcare services, insurance and other allied segments.
- The fund will be managed by Aditya Khemani and benchmarked against the BSE Healthcare TRI.
- The NFO will remain open from August 18 to September 1, 2026.
- The minimum investment is Rs. 1,000 for lump-sum investments and Rs. 100 for SIPs.
- An exit load of 0.50% will be charged if units are redeemed or switched out within three months of allotment. No exit load will be charged thereafter.
“The next phase of wealth creation may belong to those who understand where smart money is moving.” — Prem Khatri, Founder & CEO, Cafemutual.
Be a part of CafeAlt Conference 2026 and explore the trends transforming India’s alternatives landscape. Gain actionable insights, hear from market leaders, and connect with the professionals driving the next wave of wealth creation.
See you on Friday, August 21, 2026, at Taj Lands End, Mumbai.
Book your seat today: www.cafemutualevents.com
Like what you are reading?
development, success stories and industry updates.
Don’t worry … it’s FREE!